Available from: 237. National Institute for Health and Clinical Excellence. Social value judgements: principles for the development of NICE guidance. London. National Institute for Health and Clinical Excellence, 2008. Available from: https://www.nice.org.uk/media/default/about/what-we- do/research-and-development/social-value-judgements-principles-for-the-development-of- nice-guidance.pdf 238. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013. London. National Institute for Health and Clinical Excellence, 2013. Available 239. NHS Business Services Authority. NHS electronic drug tariff, May 2017. 2015. Available from: http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx Last accessed: 06/12/18. 240. NHS Business Services Authority. NHS electronic drug tariff May 2016. 2016. Available from: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff Last accessed: 27/11/2017. 241. NHS Commissioning Assembly. Technology enabled care services : resource for commissioners. 2015. Available from: https://www.england.nhs.uk/wp- 242. NHS England. Reference costs 2014- 15. Department of Health, 2015. Available from: 243. Nielsen LS, Svanegaard J, Klitgaard NA, Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. European Journal of Heart 244. Nucifora G, Albanese MC, De Biaggio P, Caliandro D, Gregori D, Goss P et al. Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management programme. Journal of Cardiovascular Medicine. 2006; 7(8):614-22 Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 245. O'Shea P, Daly R, Kasim S, Tormey WP. B-type natriuretic peptide in the cardiology department. Irish Medical Journal. 2012; 105(10):341-3 246. Ojeda S, Anguita M, Delgado M, Atienza F, Rus C, Granados AL et al. Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: are effects maintained after stopping the programme? European Journal of 247. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT et al. 